Senti Biosciences Holdings, Inc. — Form 8-K
Filed August 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Senti Biosciences filed an 8-K on August 20, 2026, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03) as of August 14, 2026. The filing provides no specific counterparty name, dollar amounts, terms, or other concrete details in the document index provided.
Why this rating
Cannot assess materiality without actual terms. Filing cites material agreement and obligation but core details (counterparty, amount, terms) absent from available text.
Extracted items
- 1.01 material agreement
- 2.03 material obligation
See more from August 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.